Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Bioavailability, safety and immunogenicity of biosimilar infliximab (BOW015) compared to reference infliximab.

Lambert J, Wyand M, Lassen C, Shneyer L, Thomson E, Knight A, Willers J, Kay J.

Int J Clin Pharmacol Ther. 2016 Apr;54(4):315-22. doi: 10.5414/CP202530.

PMID:
26952037
2.

In response.

Freeman BJ, Ludbrook GL, Hall S, Cousins M, Mitchell B, Jaros M, Wyand M, Wyand M, Gorman JR.

Spine (Phila Pa 1976). 2014 Jul 1;39(15):1263. doi: 10.1097/BRS.0000000000000427. No abstract available.

PMID:
25171071
3.

Companion confidence in the balance of community-dwelling older adults: implications for physical activity promotion.

Cavanaugh JT, Dunfey JC, Wyand MK.

J Geriatr Phys Ther. 2014 Jul-Sep;37(3):121-6. doi: 10.1519/JPT.0b013e3182abe7c0.

PMID:
24406710
4.

Randomized, double-blind, placebo-controlled, trial of transforaminal epidural etanercept for the treatment of symptomatic lumbar disc herniation.

Freeman BJ, Ludbrook GL, Hall S, Cousins M, Mitchell B, Jaros M, Wyand M, Gorman JR.

Spine (Phila Pa 1976). 2013 Nov 1;38(23):1986-94. doi: 10.1097/01.brs.0000435140.61593.4c.

PMID:
24165696
5.

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer.

Kantoff PW, Schuetz TJ, Blumenstein BA, Glode LM, Bilhartz DL, Wyand M, Manson K, Panicali DL, Laus R, Schlom J, Dahut WL, Arlen PM, Gulley JL, Godfrey WR.

J Clin Oncol. 2010 Mar 1;28(7):1099-105. doi: 10.1200/JCO.2009.25.0597. Epub 2010 Jan 25.

6.

Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors.

Santra S, Sun Y, Parvani JG, Philippon V, Wyand MS, Manson K, Gomez-Yafal A, Mazzara G, Panicali D, Markham PD, Montefiori DC, Letvin NL.

J Virol. 2007 Aug;81(16):8563-70. Epub 2007 Jun 6.

7.

Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques.

Schmitz JE, Johnson RP, McClure HM, Manson KH, Wyand MS, Kuroda MJ, Lifton MA, Khunkhun RS, McEvers KJ, Gillis J, Piatak M, Lifson JD, Grosschupff G, Racz P, Tenner-Racz K, Rieber EP, Kuus-Reichel K, Gelman RS, Letvin NL, Montefiori DC, Ruprecht RM, Desrosiers RC, Reimann KA.

J Virol. 2005 Jul;79(13):8131-41.

8.

Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques.

Abdel-Motal UM, Gillis J, Manson K, Wyand M, Montefiori D, Stefano-Cole K, Montelaro RC, Altman JD, Johnson RP.

Virology. 2005 Mar 15;333(2):226-38.

9.

Vaccination with gp120-depleted HIV-1 plus immunostimulatory CpG oligodeoxynucleotides in incomplete Freund's adjuvant stimulates cellular and humoral immunity in rhesus macaques.

Silvera P, Savary JR, Livingston V, White J, Manson KH, Wyand MH, Salk PL, Moss RB, Lewis MG.

Vaccine. 2004 Dec 21;23(6):827-39.

PMID:
15542208
10.

Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine.

Voss G, Manson K, Montefiori D, Watkins DI, Heeney J, Wyand M, Cohen J, Bruck C.

J Virol. 2003 Jan;77(2):1049-58.

11.

Induction of immune responses and safety profiles in rhesus macaques immunized with a DNA vaccine expressing human prostate specific antigen.

Kim JJ, Yang JS, Nottingham LK, Tang W, Dang K, Manson KH, Wyand MS, Wilson DM, Weiner DB.

Oncogene. 2001 Jul 27;20(33):4497-506.

12.

Protection from immunodeficiency virus challenges in rhesus macaques by multicomponent DNA immunization.

Kim JJ, Yang JS, Nottingham LK, Lee DJ, Lee M, Manson KH, Wyand MS, Boyer JD, Ugen KE, Weiner DB.

Virology. 2001 Jul 5;285(2):204-17.

13.

Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions.

Wang SW, Kozlowski PA, Schmelz G, Manson K, Wyand MS, Glickman R, Montefiori D, Lifson JD, Johnson RP, Neutra MR, Aldovini A.

J Virol. 2000 Nov;74(22):10514-22.

14.

Effect of a cellulose acetate phthalate topical cream on vaginal transmission of simian immunodeficiency virus in rhesus monkeys.

Manson KH, Wyand MS, Miller C, Neurath AR.

Antimicrob Agents Chemother. 2000 Nov;44(11):3199-202.

15.

Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.

Egan MA, Charini WA, Kuroda MJ, Schmitz JE, Racz P, Tenner-Racz K, Manson K, Wyand M, Lifton MA, Nickerson CE, Fu T, Shiver JW, Letvin NL.

J Virol. 2000 Aug;74(16):7485-95.

16.

Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants.

Kim JJ, Yang JS, VanCott TC, Lee DJ, Manson KH, Wyand MS, Boyer JD, Ugen KE, Weiner DB.

J Virol. 2000 Apr;74(7):3427-9.

17.

Antigen-specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN-gamma, IL-12, or IL-18 gene adjuvants.

Kim JJ, Nottingham LK, Tsai A, Lee DJ, Maguire HC, Oh J, Dentchev T, Manson KH, Wyand MS, Agadjanyan MG, Ugen KE, Weiner DB.

J Med Primatol. 1999 Aug-Oct;28(4-5):214-23.

PMID:
10593488
18.

Characterization of primary isolate-like variants of simian-human immunodeficiency virus.

Crawford JM, Earl PL, Moss B, Reimann KA, Wyand MS, Manson KH, Bilska M, Zhou JT, Pauza CD, Parren PW, Burton DR, Sodroski JG, Letvin NL, Montefiori DC.

J Virol. 1999 Dec;73(12):10199-207.

19.

Protection by live, attenuated simian immunodeficiency virus against heterologous challenge.

Wyand MS, Manson K, Montefiori DC, Lifson JD, Johnson RP, Desrosiers RC.

J Virol. 1999 Oct;73(10):8356-63.

20.

Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation.

Johnson RP, Lifson JD, Czajak SC, Cole KS, Manson KH, Glickman R, Yang J, Montefiori DC, Montelaro R, Wyand MS, Desrosiers RC.

J Virol. 1999 Jun;73(6):4952-61.

21.

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations.

Robinson HL, Montefiori DC, Johnson RP, Manson KH, Kalish ML, Lifson JD, Rizvi TA, Lu S, Hu SL, Mazzara GP, Panicali DL, Herndon JG, Glickman R, Candido MA, Lydy SL, Wyand MS, McClure HM.

Nat Med. 1999 May;5(5):526-34.

PMID:
10229229
22.

Effect of 3-hydroxyphthaloyl-beta-lactoglobulin on vaginal transmission of simian immunodeficiency virus in rhesus monkeys.

Wyand MS, Manson KH, Miller CJ, Neurath AR.

Antimicrob Agents Chemother. 1999 Apr;43(4):978-80.

23.

Neutralizing antibodies in sera from macaques immunized with attenuated simian immunodeficiency virus.

Langlois AJ, Desrosiers RC, Lewis MG, KewalRamani VN, Littman DR, Zhou JY, Manson K, Wyand MS, Bolognesi DP, Montefiori DC.

J Virol. 1998 Aug;72(8):6950-5.

25.

Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity.

Cole KS, Rowles JL, Jagerski BA, Murphey-Corb M, Unangst T, Clements JE, Robinson J, Wyand MS, Desrosiers RC, Montelaro RC.

J Virol. 1997 Jul;71(7):5069-79.

26.

SIV DNA vaccine trial in macaques: post-challenge necropsy in vaccine and control groups.

Lu S, Manson K, Wyand M, Robinson HL.

Vaccine. 1997 Jun;15(8):920-3.

PMID:
9234548
27.

Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus.

Wyand MS, Manson KH, Lackner AA, Desrosiers RC.

Nat Med. 1997 Jan;3(1):32-6.

PMID:
8986737
28.

Utility of SHIV for testing HIV-1 vaccine candidates in macaques.

Lu Y, Salvato MS, Pauza CD, Li J, Sodroski J, Manson K, Wyand M, Letvin N, Jenkins S, Touzjian N, Chutkowski C, Kushner N, LeFaile M, Payne LG, Roberts B.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jun 1;12(2):99-106.

PMID:
8680896
29.

Simian immunodeficiency virus DNA vaccine trial in macaques.

Lu S, Arthos J, Montefiori DC, Yasutomi Y, Manson K, Mustafa F, Johnson E, Santoro JC, Wissink J, Mullins JI, Haynes JR, Letvin NL, Wyand M, Robinson HL.

J Virol. 1996 Jun;70(6):3978-91.

30.

Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.

Wyand MS, Manson KH, Garcia-Moll M, Montefiori D, Desrosiers RC.

J Virol. 1996 Jun;70(6):3724-33.

31.

DNA vaccines.

Robinson HL, Lu S, Feltquate DM, Torres CT, Richmond J, Boyle CM, Morin MJ, Santoro JC, Webster RG, Montefiori D, Yasutomi Y, Letvin NL, Manson K, Wyand M, Haynes JR.

AIDS Res Hum Retroviruses. 1996 Mar 20;12(5):455-7. Review. No abstract available.

PMID:
8962755
32.

Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys.

Yasutomi Y, Robinson HL, Lu S, Mustafa F, Lekutis C, Arthos J, Mullins JI, Voss G, Manson K, Wyand M, Letvin NL.

J Virol. 1996 Jan;70(1):678-81.

33.
34.

Induction of antigen-specific killer T lymphocyte responses using subunit SIVmac251 gag and env vaccines containing QS-21 saponin adjuvant.

Newman MJ, Munroe KJ, Anderson CA, Murphy CI, Panicali DL, Seals JR, Wu JY, Wyand MS, Kensil CR.

AIDS Res Hum Retroviruses. 1994 Jul;10(7):853-61.

PMID:
7986590
36.

Mucosal infection of neonatal rhesus monkeys with cell-free SIV.

Baba TW, Koch J, Mittler ES, Greene M, Wyand M, Penninck D, Ruprecht RM.

AIDS Res Hum Retroviruses. 1994 Apr;10(4):351-7.

PMID:
8068415
37.

Animal models for perinatal transmission of pathogenic viruses.

Ruprecht RM, Fratazzi C, Sharma PL, Greene MF, Penninck D, Wyand M.

Ann N Y Acad Sci. 1993 Oct 29;693:213-28. Review.

PMID:
8267266
38.

Use of particulate forms of protein antigens to increase the sensitivity of antigen-specific proliferation assays.

Wu JY, Munroe KJ, Gardner BH, Wyand MS, Newman MJ.

J Immunol Methods. 1993 Feb 26;159(1-2):39-45.

PMID:
8445264
39.

Simian immunodeficiency virus infection via amniotic fluid: a model to study fetal immunopathogenesis and prophylaxis.

Fazely F, Sharma PL, Fratazzi C, Greene MF, Wyand MS, Memon MA, Penninck D, Ruprecht RM.

J Acquir Immune Defic Syndr. 1993 Feb;6(2):107-14.

PMID:
8433276
40.

Arteriopathy in macaques infected with simian immunodeficiency virus.

Chalifoux LV, Simon MA, Pauley DR, MacKey JJ, Wyand MS, Ringler DJ.

Lab Invest. 1992 Sep;67(3):338-49.

PMID:
1405492
41.

Immunogenicity and toxicity testing of an experimental HIV-1 vaccine in nonhuman primates.

Newman MJ, Wu JY, Coughlin RT, Murphy CI, Seals JR, Wyand MS, Kensil CR.

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1413-8.

PMID:
1466970
42.

The use of SIV-infected rhesus monkeys for the preclinical evaluation of AIDS drugs and vaccines.

Wyand MS.

AIDS Res Hum Retroviruses. 1992 Mar;8(3):349-56. Review.

PMID:
1571195
43.

Risks of handling HIV.

Letvin NL, Lord CI, King NW, Wyand MS, Myrick KV, Haseltine WA.

Nature. 1991 Feb 14;349(6310):573. No abstract available.

PMID:
2000134
44.

Study of long-term cultures of simian immunodeficiency virus (SIVmac 251)-infected peripheral blood lymphocytes.

Montaner LJ, Ringler DJ, Wyand MS, Mattmuller MR, MacKey JJ, Schmidt DK, Daniel MD, King NW.

Lab Invest. 1990 Aug;63(2):242-7.

PMID:
1696333
45.

Use of simian immunodeficiency virus for vaccine research.

Daniel MD, Sehgal PK, Kodama T, Wyand MS, Ringler DJ, King NW, Schmidt DK, Troup CD, Desrosiers RC.

J Med Primatol. 1990;19(3-4):395-9.

PMID:
2231691
46.

Comparative biology of natural and experimental SIVmac infection in macaque monkeys: a review.

King NW, Chalifoux LV, Ringler DJ, Wyand MS, Sehgal PK, Daniel MD, Letvin NL, Desrosiers RC, Blake BJ, Hunt RD.

J Med Primatol. 1990;19(2):109-18.

PMID:
2160016
47.

Vaccine protection against simian immunodeficiency virus infection.

Desrosiers RC, Wyand MS, Kodama T, Ringler DJ, Arthur LO, Sehgal PK, Letvin NL, King NW, Daniel MD.

Proc Natl Acad Sci U S A. 1989 Aug;86(16):6353-7.

48.

Cellular localization of simian immunodeficiency virus in lymphoid tissues. II. In situ hybridization.

Wyand MS, Ringler DJ, Naidu YM, Mattmuller M, Chalifoux LV, Sehgal PK, Daniel MD, Desrosiers RC, King NW.

Am J Pathol. 1989 Feb;134(2):385-93.

49.

Cellular localization of simian immunodeficiency virus in lymphoid tissues. I. Immunohistochemistry and electron microscopy.

Ringler DJ, Wyand MS, Walsh DG, MacKey JJ, Chalifoux LV, Popovic M, Minassian AA, Sehgal PK, Daniel MD, Desrosiers RC, et al.

Am J Pathol. 1989 Feb;134(2):373-83.

50.

Detection of simian immunodeficiency virus in macaque lymph nodes with a SIVmac envelope probe.

Wyand MS, Ringler DJ, Mattmuller M, Daniel MD, Desrosiers RC, King NW.

J Med Primatol. 1989;18(3-4):209-15.

PMID:
2547958

Supplemental Content

Support Center